Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Combine Tesamorelin Ipamorelin Synergy Dosing Timing: Research Protocol Comparison

Single Morning Pulse 1–2mg 200–300mcg Fasted, 30–60 min before first meal; Tesamorelin first, Ipamorelin 15–30 min later 150–220% Fat loss focus; capitalizes on fasted state insulin sensitivity Post-Training Pulse 1mg 200mcg 90–120 min after resistance trainin

This comparison does not assign a generated winner or score.

  • Single Morning Pulse
  • 1–2mg
  • 200–300mcg
  • Fasted, 30–60 min before first meal; Tesamorelin first, Ipamorelin 15–30 min later
  • 150–220%
  • Fat loss focus; capitalizes on fasted state insulin sensitivity
  • Post-Training Pulse
  • 1mg
  • 200mcg
  • 90–120 min after resistance training; staggered 15 min apart
  • 180–250%
  • Muscle retention during caloric deficit; leverages exercise-induced GH elevation
  • Dual Daily Pulse
  • 1mg AM / 1mg PM
  • 200mcg AM / 200mcg PM
  • Morning fasted + pre-sleep (2–3 hours post-meal); both staggered
  • 200–280% (cumulative)
  • Research examining sustained lipolysis; requires strict meal timing to avoid insulin blunting
  • High-Intensity Research
  • 2mg
  • 300mcg
  • Single morning fasted dose; 20 min stagger
  • 250–320%
  • Visceral adiposity studies; mimics EGRIFTA clinical trial design
  • Professional Assessment
  • Dose escalation from low ranges establishes individual response before advancing to higher protocols; post-training timing produces superior muscle-sparing effects during energy restriction
More references

Related material